针对黑色素瘤的T细胞免疫疗法
Cristian Mantilla Rosa1, Aparna Vancheswaran1, Charlotte E Ariyan1
1Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Surgical oncology
|November 23, 2024
概括
本综述涵盖了T细胞免疫疗法治疗黑色素瘤,包括免疫检查点抑制剂,瘤透性淋巴细胞 (TILs) 和工程T细胞疗法,如CAR-T和TCR细胞. 它还探讨了RNA疫苗和未来的方向,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
背景情况:
- 黑色素瘤是一种重要的皮肤癌,治疗风景不断变化.
- T细胞免疫疗法彻底改变了癌症治疗,特别是黑色素瘤的治疗.
- 了解不同的T细胞策略对于推进黑色素瘤治疗至关重要.
研究的目的:
- 为提供对T细胞免疫治疗黑色素瘤的全面概述.
- 详细介绍当前和新兴T细胞疗法的机制和应用.
- 讨论改善基于T细胞的黑色素瘤治疗的未来前景.
主要方法:
- 对黑色素瘤T细胞免疫疗法的文献综述.
- 对免疫检查点抑制剂 (抗CTLA-4,抗PD-1,抗LAG-3) 的分析.
- 探索瘤透淋巴细胞 (TIL) 和工程T细胞疗法 (CAR-T,TCR).
- 审查RNA疫苗及其在黑色素瘤免疫治疗中的作用.
主要成果:
- 免疫检查点抑制剂在黑色素瘤治疗中显示出显著的疗效.
- 瘤透淋巴细胞 (TILs) 为黑色素瘤免疫疗法提供了个性化的方法.
- 工程T细胞疗法,包括CAR-T和TCR,代表了有前途的下一代治疗方法.
- RNA疫苗正在成为黑色素瘤免疫疗法的新战略.
结论:
- T细胞免疫疗法包括一系列针对黑色素瘤的强大策略.
- 结合不同的T细胞方法可以改善患者的反应和结果.
- 对新型T细胞疗法和疫苗的持续研究对于推动黑色素瘤治疗至关重要.
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849


